“…Given the unique physical state of these distinct habitats, we reason that strains adapted to different environments should maintain unique metabolic pathways capable of producing diverse secondary metabolites that may exhibit antimicrobial effects against other bacteria. Moreover, pseudomonads have been shown to breakdown refractory recalcitrant compounds such as chloroanilines (Nitisakulkan et al., ), insecticides (Pinjari, Pandey, Kamireddy, & Siddavattam, ), and chitin (Thompson, Smith, Wilkinson, & Peek, ), inhibit the growth of pathogenic plant fungi (Nielsen, Sorensen, Fels, & Pedersen, ; Nielsen, Thrane, Christophersen, Anthoni, & Sorensen, ; Tran, Ficke, Asiimwe, Hofte, & Raaijmakers, ), exhibit antitumor activity (Ikeda et al., ; Ni et al., ), and inhibit growth of a wide range of bacteria including human pathogens of MRSA (Farrow & Pesci, ; Rode, Hanslo, de Wet, Millar, & Cywes, ), Mycobacterium tuberculosis (Gerard et al., ), collections of gramāpositive and gramānegative bacteria (Ye et al., ), and P. aeruginosa isolated from cystic fibrosis patients (Chatterjee et al., ). Thus, Pseudomonas spp.…”